For a long time in the past, all efforts in the treatment of AD targeting the pathogenic Aβ or tau have failed to demonstrate clinical efficiency unfortunately [6, 7], suggesting that the pathogenesis of AD should be quite complex and multifactorial [8]. Here, MAPT is linked to Alzheimer disease.